PURPOSE: Granulocyte colony stimulating factor (G-CSF) has been shown to have neuroprotective and anti-inflammatory effects in cerebral damage models. In addition, bone-marrow-derived hematopoietic cells, which can be mobilized with G-CSF, have a neuroprotective effect in hereditary retinal cell death. The present study was conducted to investigate whether G-CSF protects photoreceptors from light-induced cell death. METHODS: G-CSF or vehicle was systemically injected before the light exposure and for four consecutive days after the exposure. Morphologic and electrophysiologic examinations were performed 1 week after the exposure to light. Gamma ray irradiation (6.5 Gy) was used to examine the involvement of bone marrow-derived cells increased by G-CSF injection. The expression of G-CSF receptor in the retina was analyzed by immunohistochemistry and quantitative RT-PCR. RESULTS: The outer nuclear layer thickness was partially preserved in G-CSF-treated mice (measured at 300 microm superior from the optic disc, G-CSF: 14.9 +/- 6.3 microm versus control: 6.7 +/- 2.5 microm), and an electroretinogram confirmed the preservation of wave amplitudes (maximum scotopic a-wave G-CSF: 97.7 +/- 48.0 microV versus control: 14.4 +/- 21.9 microV, maximum scotopic b-wave G-CSF: 298.1 +/- 145.3 microV versus control: 33.2 +/- 50.1 microV). The effect was not lost, even with leukocyte depletion by irradiation. G-CSF receptor was expressed in retinal cells and upregulated by the light exposure (1.8-fold upregulation 2 hours after light exposure). CONCLUSIONS: G-CSF protects photoreceptor cells against light-induced damage, possibly via G-CSF receptor expressed on retinal cells. These findings may lead to a novel treatment strategy for neural degenerating diseases of the retina.
PURPOSE:Granulocyte colony stimulating factor (G-CSF) has been shown to have neuroprotective and anti-inflammatory effects in cerebral damage models. In addition, bone-marrow-derived hematopoietic cells, which can be mobilized with G-CSF, have a neuroprotective effect in hereditary retinal cell death. The present study was conducted to investigate whether G-CSF protects photoreceptors from light-induced cell death. METHODS:G-CSF or vehicle was systemically injected before the light exposure and for four consecutive days after the exposure. Morphologic and electrophysiologic examinations were performed 1 week after the exposure to light. Gamma ray irradiation (6.5 Gy) was used to examine the involvement of bone marrow-derived cells increased by G-CSF injection. The expression of G-CSF receptor in the retina was analyzed by immunohistochemistry and quantitative RT-PCR. RESULTS: The outer nuclear layer thickness was partially preserved in G-CSF-treated mice (measured at 300 microm superior from the optic disc, G-CSF: 14.9 +/- 6.3 microm versus control: 6.7 +/- 2.5 microm), and an electroretinogram confirmed the preservation of wave amplitudes (maximum scotopic a-wave G-CSF: 97.7 +/- 48.0 microV versus control: 14.4 +/- 21.9 microV, maximum scotopic b-wave G-CSF: 298.1 +/- 145.3 microV versus control: 33.2 +/- 50.1 microV). The effect was not lost, even with leukocyte depletion by irradiation. G-CSF receptor was expressed in retinal cells and upregulated by the light exposure (1.8-fold upregulation 2 hours after light exposure). CONCLUSIONS:G-CSF protects photoreceptor cells against light-induced damage, possibly via G-CSF receptor expressed on retinal cells. These findings may lead to a novel treatment strategy for neural degenerating diseases of the retina.
Authors: Khaled A Hussein; Karishma Choksi; Sara Akeel; Saif Ahmad; Sylvia Megyerdi; Mohamed El-Sherbiny; Mohamed Nawaz; Ahmed Abu El-Asrar; Mohamed Al-Shabrawey Journal: Exp Eye Res Date: 2014-06-06 Impact factor: 3.467
Authors: Craig R Wright; Erin L Brown; Paul A Della-Gatta; Alister C Ward; Gordon S Lynch; Aaron P Russell Journal: Front Physiol Date: 2014-05-01 Impact factor: 4.566
Authors: Lee Kiang; Bing X Ross; Jingyu Yao; Sumathi Shanmugam; Chris A Andrews; Sean Hansen; Cagri G Besirli; David N Zacks; Steven F Abcouwer Journal: Invest Ophthalmol Vis Sci Date: 2018-07-02 Impact factor: 4.799